Sterling Investment Advisors, Ltd. Moderna, Inc. Transaction History

Sterling Investment Advisors, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$117.13 - $176.59 $14,055 - $21,190	120 Added 18.32%	775 $111,000
Q1 2022 May 03, 2022	BUY	$126.46 - $235.05 $41,099 - $76,391	325 Added 98.48%	655 $113,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $22,582 - $36,851	100 Added 43.48%	330 $84,000
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $2,219 - $4,844	-10 Reduced 4.17%	230 $89,000
Q1 2021 May 04, 2021	BUY	$109.18 - $185.98 $20,744 - $35,336	190 Added 380.0%	240 $31,000
Q4 2020 Jan 21, 2021	SELL	$65.74 - $169.86 $34,316 - $88,666	-522 Reduced 91.26%	50 $5,000
Q3 2020 Oct 26, 2020	BUY	$54.34 - $94.85 $30,539 - $53,305	562 Added 5620.0%	572 $40,000
Q2 2020 Jul 24, 2020	BUY	$29.67 - $80.0 $296 - $800	10 New	10 $0

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.